KoreaMed, a service of the Korean Association of Medical Journal Editors (KAMJE), provides access to articles published in Korean medical, dental, nursing, nutrition and veterinary journals. KoreaMed records include links to full-text content in Synapse and publisher web sites.
Effectiveness of hemocoagulase, tranexamic acid, and their combination for reducing blood loss in bimaxillary orthognathic surgery:
a retrospective study
Objectives Orthognathic surgery is a corrective intervention for maxillofacial deformities. Bleeding is a major concern for oral and maxillofacial surgeons. Various agents, such as hemocoagulase, tranexamic acid, and aprotinin have been developed to reduce intraoperative bleeding and transfusion requirements. Therefore, in this study we aimed to investigate the effects of hemocoagulase and tranexamic acid, as well as their simultaneous use, to reduce bleeding during orthognathic surgery.
Patients and Methods This retrospective study included patients who had undergone simultaneous orthognathic surgery of the maxilla and mandible between January 2013 and September 2022 and were classified into three groups based on drugs administered: hemocoagulase (Botropase), tranexamic acid, and a combination of both drugs. We recorded patient age, sex, weight, blood loss, and duration of surgery. Red blood cell (RBC), hemoglobin, hematocrit, and platelet levels were measured before, immediately after, and one day after surgery.
Results No statistically significant differences were found in blood loss, RBC, hemoglobin, hematocrit, or platelet levels between any of the groups.
There were no differences in the drug effects between Le Fort I and bilateral mandibular sagittal split osteotomies, with or without double genioplasty.
However, there were significant reductions in RBC, hemoglobin, hematocrit, and platelet levels during genioplasty.
Conclusion Tranexamic acid, hemocoagulase, and their combination had similar efficacy in patients who underwent Le Fort Ⅰ and bilateral mandibu-lar sagittal split osteotomies with and without genioplasty.
2. Jeong J, Portnof JE, Kalayeh M, Hardigan P. 2016; Hypotensive anesthesia: comparing the effects of different drug combinations on mean arterial pressure, estimated blood loss, and surgery time in orthognathic surgery. J Craniomaxillofac Surg. 44:854–8. https://doi.org/10.1016/j.jcms.2016.04.009. DOI: 10.1016/j.jcms.2016.04.009. PMID: 27193474. Article
3. Apipan B, Rummasak D. 2010; Efficacy and safety of oral propranolol premedication to reduce reflex tachycardia during hypotensive anesthesia with sodium nitroprusside in orthognathic surgery: a double-blind randomized clinical trial. J Oral Maxillofac Surg. 68:120–4. https://doi.org/10.1016/j.joms.2009.07.065. DOI: 10.1016/j.joms.2009.07.065. PMID: 20006165. Article
6. Nagabhushan RM, Shetty AP, Dumpa SR, Subramanian B, Kanna RM, Shanmuganathan R. 2018; Effectiveness and safety of batroxobin, tranexamic acid and a combination in reduction of blood loss in lumbar spinal fusion surgery. Spine (Phila Pa 1976). 43:E267–73. https://doi.org/10.1097/brs.0000000000002315. DOI: 10.1097/BRS.0000000000002315. PMID: 28678111. Article
14. Christabel A, Muthusekhar MR, Narayanan V, Ashok Y, Soh CL, Ilangovan M, et al. 2014; Effectiveness of tranexamic acid on intraoperative blood loss in isolated Le Fort I osteotomies--a prospective, triple blinded randomized clinical trial. J Craniomaxillofac Surg. 42:1221–4. https://doi.org/10.1016/j.jcms.2014.03.003. DOI: 10.1016/j.jcms.2014.03.003. PMID: 24776218. Article